The Evidence Based Rheumatology Podcast
Health & Fitness:Medicine
Today I'll be reading one of my recent newsletters! It's kind of a fun run-down of my anti-azathioprine stance. As I say in the piece, some patients may benefit from azathioprine and I am not saying it is an entirely useless drug or that nobody should ever prescribe it. Rather, I am just saying that it is likely the worst option for nearly every indication for which it could be prescribed.
Please subscribe AND JOIN my newsletter if you would like to support my writing and podcasting! https://t.co/RIzRvWnSfv
E91: Clinical Innovation in Rheumatology: Past, Present, and Future
E90: There Is No Diagnosis of Exclusion in Rheumatology
E89: Vitamin D to Prevent Osteoporotic Fractures
E88: HCQ Dose Reductions and SLE Flares
E87: IVIG for Dermatomyositis
E86: Target Trials and Causality in Rheumatology
E85: Challenging Wisely
E84: The JAKapocalypse (AKA ORAL Surveillance)
E83: Effectiveness of COVID-19 Vaccines
E82: LoVAS Trial for ANCA Vasculitis
E81: Vasculitis Guidelines E7: Takayasu Arteritis with Dr. Andy Abril
E80: Vasculitis Guidelines E6 - Polyarteritis Nodosa with Dr. Jason Springer
E79: Vasculitis Guidelines E5 - GCA with Dr. Mehrdad Maz
E78: Vasculitis Guidelines #4 - EGPA with Dr. Phil Seo
E77: Vasculitis Guidelines #3 - ANCA Vasculitis with Dr. Sharon Chung
E76: Voclosporin for SLE Nephritis: The AURORA RCT
E75: Vasculitis Guidelines Episode 2: Overview with Sharon Chung
E74: Vasculitis Guidelines Episode 1 - Joyce Kullman
E73: Introducing the Vasculitis Guidelines Podcast
E72: Avacopan for ANCA Vasculitis
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive